Clinical research

Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?

EuroIntervention 2013;9:620-628. DOI: 10.4244/EIJV9I5A99

Martin Unverdorben
Martin Unverdorben1, MD; Franz X. Kleber2, MD; Hubertus Heuer3, MD; Hans-Reiner Figulla4, MD; Christian Vallbracht5, MD; Matthias Leschke6, MD; Bodo Cremers7, MD; Stefan Hardt8, MD; Michael Buerke9, MD; Hanns Ackermann10, PhD; Michael Boxberger11, PhD ; Ralf Degenhardt1, PhD; Bruno Scheller7*, MD
1. Institut für Klinische Forschung, Herz- und Kreislaufzentrum, Rotenburg an der Fulda, Germany; 2. Klinik für Innere Medizin, Unfallkrankenhaus Berlin, Charité Universitätsmedizin, Berlin, Germany; 3. Medizinische Klinik, Kardiologie,

Aims: The one-year outcome of lesions in small coronary arteries by using a paclitaxel-iopromide-coated (3 µg/mm²) balloon catheter (DCB) has yielded good six-month angiographic and one-y

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

dcb onlydrug-coated balloonsmall coronary vessels
Read next article
Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale

Latest news